LETROZOLE FARMOZ

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

LETROZOLE

Disponible desde:

BIOAVENIR LTD, ISRAEL

Código ATC:

L02BG04

formulario farmacéutico:

FILM COATED TABLETS

Composición:

LETROZOLE 2.5 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

WEST PHARMA - PRODUCOES. DE ESPECIALIDADES FARMACEUTICA S.A., PORTUGAL

Grupo terapéutico:

LETROZOLE

Área terapéutica:

LETROZOLE

indicaciones terapéuticas:

Letrozole Farmoz tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole Farmoz is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Fecha de autorización:

2014-12-31